Inovio Pharmaceuticals Inc vs Match Group Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $76.09M), while Match Group Inc trades at $36.82 (market cap $8.43B). The key difference: Match Group Inc is far larger — about 110.8× Inovio Pharmaceuticals Inc's market cap, and Match Group Inc pays a 2.18% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | MTCH | |
|---|---|---|
Market Cap | $76.09M | $8.43B |
Sector | Health | Media |
52-Week High | $2.87 | $41.24 |
52-Week Low | $0.66 | $28.90 |
Enterprise Value | $47.10M | $11.40B |
Dividend Yield | — | 2.18% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →